Tokyo, Japan

Hiromi Yoshihara

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kureha Kagaku Kogyo K.k.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiromi Yoshihara. Retrieved from https://idiyas.com/inventor/hiromi-yoshihara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Hiromi Yoshihara: Innovating Nephritis Diagnosis**

Introduction

Hiromi Yoshihara is a notable inventor based in Tokyo, Japan. With a focus on medical innovations, he has developed a significant patent that enhances the diagnosis of nephritis.

Latest Patents

Yoshihara holds a patent for a "Method of testing for nephritis." This invention introduces an acetyltransferase activity measuring agent that contains an arylamine derivative, specifically sodium p-aminohippurate. This method allows for simple and safe diagnosis of nephritis progression, particularly in cases involving mesangial proliferative lesions or renal insufficiency. The agent minimizes the dispersion of measured values, which contributes to more accurate diagnoses.

Career Highlights

Currently, Hiromi Yoshihara is associated with Kureha Kagaku Kogyo Co., Ltd. His role at the company reflects his dedication to advancing diagnostic techniques in the medical field.

Collaborations

Yoshihara collaborates with esteemed coworkers, including Chikau Onodera and Mikiro Yanaka. These partnerships contribute to the research and development of innovative solutions for nephritis and other medical conditions.

Conclusion

Hiromi Yoshihara exemplifies the impactful role of inventors in the medical field. His advancements in nephritis diagnosis not only showcase his innovative spirit but also highlight the importance of collaboration in scientific research. With continued efforts, his contributions have the potential to improve patient outcomes significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…